These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28401117)

  • 21. Prescription medication nonadherence associated with food insecurity: a population-based cross-sectional study.
    Men F; Gundersen C; Urquia ML; Tarasuk V
    CMAJ Open; 2019; 7(3):E590-E597. PubMed ID: 31551236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer History, Health Insurance Coverage, and Cost-Related Medication Nonadherence and Medication Cost-Coping Strategies in the United States.
    Zhao J; Zheng Z; Han X; Davidoff AJ; Banegas MP; Rai A; Jemal A; Yabroff KR
    Value Health; 2019 Jul; 22(7):762-767. PubMed ID: 31277821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017.
    Khera R; Valero-Elizondo J; Das SR; Virani SS; Kash BA; de Lemos JA; Krumholz HM; Nasir K
    Circulation; 2019 Dec; 140(25):2067-2075. PubMed ID: 31760784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant disparities in eyeglass insurance coverage in Canada.
    Ngo G; Trope G; Buys Y; Jin YP
    Can J Ophthalmol; 2018 Jun; 53(3):260-265. PubMed ID: 29784163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of health care resources by obese Canadians.
    Trakas K; Lawrence K; Shear NH
    CMAJ; 1999 May; 160(10):1457-62. PubMed ID: 10352635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.
    Morgan SG; Li W; Yau B; Persaud N
    CMAJ; 2017 Feb; 189(8):E295-E302. PubMed ID: 28246223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Income, dental insurance coverage, and financial barriers to dental care among Canadian adults.
    Locker D; Maggirias J; Quiñonez C
    J Public Health Dent; 2011; 71(4):327-34. PubMed ID: 22320291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Private Insurance Coverage on Prescription Drug Use in Ontario, Canada.
    Kratzer J; Cheng L; Allin S; Law MR
    Healthc Policy; 2015 May; 10(4):62-74. PubMed ID: 26142359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot study on cost-related medication nonadherence in Ontario.
    Zheng B; Poulose A; Fulford M; Holbrook A
    J Popul Ther Clin Pharmacol; 2012; 19(2):e239-47. PubMed ID: 22805096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease.
    Frankenfield DL; Howell BL; Wei II; Anderson KK
    Am J Health Syst Pharm; 2011 Jul; 68(14):1339-48. PubMed ID: 21719594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What can the Canadians and Americans learn from each other's health care systems?
    Weil TP
    Int J Health Plann Manage; 2016 Jul; 31(3):349-70. PubMed ID: 27469581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression and cost-related medication nonadherence in Medicare beneficiaries.
    Bambauer KZ; Safran DG; Ross-Degnan D; Zhang F; Adams AS; Gurwitz J; Pierre-Jacques M; Soumerai SB
    Arch Gen Psychiatry; 2007 May; 64(5):602-8. PubMed ID: 17485612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of self-reported adherence to antihypertensive medicines: a multinational, cross-sectional survey.
    Morrison VL; Holmes EA; Parveen S; Plumpton CO; Clyne W; De Geest S; Dobbels F; Vrijens B; Kardas P; Hughes DA
    Value Health; 2015 Mar; 18(2):206-16. PubMed ID: 25773556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disparities in prescription drug insurance coverage.
    Millar WJ
    Health Rep; 1999; 10(4):11-31(ENG); 9-30(FRE). PubMed ID: 10607410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-related medication nonadherence in Canada: a systematic review of prevalence, predictors, and clinical impact.
    Holbrook AM; Wang M; Lee M; Chen Z; Garcia M; Nguyen L; Ford A; Manji S; Law MR
    Syst Rev; 2021 Jan; 10(1):11. PubMed ID: 33407875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Who's the fairest of them all? Which provincial pharmacare model would best protect Canadians against catastrophic drug costs?
    Coombes ME; Morgan SG; Barer ML; Pagliccia N
    Healthc Q; 2004; 7(4):suppl 13-9. PubMed ID: 15540402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in employer-sponsored private health insurance among retirees in Ontario: a cross-sectional study.
    Chan FKI; McGrail K; Majumdar SR; Law MR
    CMAJ Open; 2019; 7(1):E15-E22. PubMed ID: 30665895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National Rates of Nonadherence to Antihypertensive Medications Among Insured Adults With Hypertension, 2015.
    Chang TE; Ritchey MD; Park S; Chang A; Odom EC; Durthaler J; Jackson SL; Loustalot F
    Hypertension; 2019 Dec; 74(6):1324-1332. PubMed ID: 31679429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM; Cioffi GA; De Moraes CG
    JAMA Ophthalmol; 2015 Sep; 133(9):985-96. PubMed ID: 26042393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Medication Nonadherence Among Adult Survivors of Stroke After Implementation of the US Affordable Care Act.
    Levine DA; Burke JF; Shannon CF; Reale BK; Chen LM
    JAMA Neurol; 2018 Dec; 75(12):1538-1541. PubMed ID: 30167647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.